[Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis].
Our investigations demonstrate high antioxidant and immunomodulating activity of prostamol-uno in benign prostatic hyperplasia and chronic prostatitis. This gives grounds for using this drug not only in benign prostatic hyperplasia but also in chronic prostatitis.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000975:Antioxidants / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D010084:Oxidation-Reduction; D010936:Plant Extracts / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism; D011472:Prostatitis / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism
D000276:Adjuvants, Immunologic; D000975:Antioxidants; D010936:Plant Extracts; C445500:Prostamol-Uno
Vliianie prostamola-uno na okislitel'nyĭ i mestnyĭ immunnyĭ status u bol'nykh s dobrokachestvennoĭ giperplazieĭ prostaty i khronicheskim prostatitom.